Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes. / Holst, J.J.; Deacon, C.F.
In: Avances en Diabetologia, Vol. 22, No. 2, 2006, p. 115-125.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Holst, JJ & Deacon, CF 2006, 'Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes', Avances en Diabetologia, vol. 22, no. 2, pp. 115-125.
APA
Holst, J. J., & Deacon, C. F. (2006). Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes. Avances en Diabetologia, 22(2), 115-125.
Vancouver
Holst JJ, Deacon CF. Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes. Avances en Diabetologia. 2006;22(2):115-125.
Author
Bibtex
@article{e8d54a3070eb11dcbee902004c4f4f50,
title = "Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes",
abstract = "Udgivelsesdato: 2006",
author = "J.J. Holst and C.F. Deacon",
year = "2006",
language = "English",
volume = "22",
pages = "115--125",
journal = "Avances en Diabetologia",
issn = "1134-3230",
publisher = "Elsevier Espana",
number = "2",
}
RIS
TY - JOUR
T1 - Role of GLP-1 analogues and DDP-IV inhibitors in the treatment of type 2 diabetes
AU - Holst, J.J.
AU - Deacon, C.F.
PY - 2006
Y1 - 2006
N2 - Udgivelsesdato: 2006
AB - Udgivelsesdato: 2006
M3 - Journal article
VL - 22
SP - 115
EP - 125
JO - Avances en Diabetologia
JF - Avances en Diabetologia
SN - 1134-3230
IS - 2
ER -
ID: 1201925